The Claim
Among older adults aged 65 and older without dementia, baseline cognitive ability modifies the association between statin use and dementia risk, such that individuals with lower baseline cognitive scores who use statins have a higher risk of developing dementia compared to those with higher baseline cognitive scores who use statins.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults without dementia, those with lower initial cognitive function who take statins have a higher risk of developing dementia than those with higher initial cognitive function who take statins.
See the scientific wording
Among older adults aged 65 and older without dementia, baseline cognitive ability modifies the association between statin use and dementia risk, with higher dementia risk observed among statin users who had lower baseline cognitive scores, suggesting that statin effects may differ by pre-existing cognitive status.
When cholesterol delivery to the brain is reduced, brain cells cannot fix damaged connections between neurons, especially in people whose brains already have weaker connections. This makes it harder for the brain to stay healthy over time, increasing the chance of memory and thinking problems.
What the research says
1 studyStudy: Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults
For older adults without dementia, taking statins doesn’t usually raise dementia risk—but if someone already has weaker memory or thinking skills when they start statins, they might be more likely to develop dementia later, though we don’t know why.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.